Abstract
The aim of this study was to investigate the therapeutic efficacy of the alpha-radioimmunotherapy of ovarian cancer in mice, using different specific activities. This study was performed by using the monoclonal antibody, MX35 F(ab')(2), labeled with the alpha-particle-emitter, 211At.
Original language | English |
---|---|
Journal | Cancer Biotherapy & Radiopharmaceuticals |
Volume | 24 |
Issue number | 4 |
Pages (from-to) | 509-13 |
Number of pages | 5 |
ISSN | 1084-9785 |
DOIs | |
Publication status | Published - 1 Aug 2009 |